Cancer screening articles from across Nature Portfolio

Cancer screening describes any procedure that aims to detect precancerous changes, such that cancer can be treated before it becomes malignant. Mammography and cervical smear tests are routine cancer-screening procedures. Ideally, the benefits of any screening procedure should outweigh the risks.

Latest Research and Reviews

Reviews | 13 March 2023

Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice

Bladder cancer is among the ten most common cancers worldwide and therefore constitutes a substantial health-care burden. This Review summarizes the global trends in bladder cancer incidence and mortality, and describes the main risk factors associated with bladder cancer occurrence and outcomes. The implications, challenges and opportunities of these epidemiological trends for public health and clinical practice are also discussed.
- Lisa M. C. van Hoogstraten
- , Alina Vrieling
- & Lambertus A. Kiemeney
Nature Reviews Clinical Oncology, 1-18
Research
13 March 2023 | Open Access

Differentiating malignant and benign eyelid lesions using deep learning
- Min Joung Lee
- , Min Kyu Yang
- & Bum-Joo Cho
Scientific Reports 13, 4103
Research
10 March 2023 | Open Access

Identifying polymorphic cis-regulatory variants as risk markers for lung carcinogenesis and chemotherapy responses in tobacco smokers from eastern India
- Debmalya Sengupta
- , Pramiti Mukhopadhyay
- & Mainak Sengupta
Scientific Reports 13, 4019
Reviews | 06 March 2023

The imperative for clinical trial diversity: Perspectives in the context of prostate-specific membrane antigen-targeted imaging
- Hae Lin Cho
- , Subha Perni
- & Edward Christopher Dee
Prostate Cancer and Prostatic Diseases, 1-5
Research
01 March 2023 | Open Access

The risk of second primary malignancies in colorectal cancer patients using calcium channel blockers
- Jana Halámková
- , Lucia Bohovicová
- & Igor Kiss
Scientific Reports 13, 3490
Research
14 February 2023 | Open Access

Clinical outcomes of colonoscopic polypectomy with strategic surveillance colonoscopies in patients with 10 or more polyps
- Jin Hwa Park
- , Seung Wook Hong
- & Jeong-Sik Byeon
Scientific Reports 13, 2604

All Research & Reviews

News and Comment

Editorial | 10 January 2023

Nomograms in PCa: where do we stand
- Riccardo Lombardo
- & Cosimo De Nunzio
Prostate Cancer and Prostatic Diseases, 1-2
Research Highlights | 04 January 2023

Targeted biopsy reduces detection of clinically insignificant cancer
- Diana Romero
Nature Reviews Clinical Oncology 20, 63
Comments & Opinion | 20 December 2022

The emerging promise of liquid biopsies in solid tumors

Liquid biopsies of circulating tumor DNA offer a non-invasive tool with many potential applications in oncology, including early cancer detection, profiling, disease prognosis, prediction of therapy response and monitoring disease status. A growing body of literature and clinical trials support an increasingly valuable role for liquid biopsies in the care of patients with solid malignancies.
- Leontios Pappas
- , Viktor A. Adalsteinsson
- & Aparna R. Parikh
Nature Cancer 3, 1420-1422
Correspondence
28 November 2022 | Open Access

Genetic risk scores may compound rather than solve the issue of prostate cancer overdiagnosis
- Rachel H. Horton
- , Malcolm G. Dunlop
- & Amit Sud
British Journal of Cancer 128, 1-2
Research Highlights | 03 November 2022

From WCC 2022
- Diana Romero
Nature Reviews Clinical Oncology 20, 2
Research Highlights | 13 October 2022

Uncertain role for colonoscopy screening

Despite a reduction in colorectal cancer incidence, a large, randomized screening study shows no impact of screening on cancer-related deaths.
- Karen O’Leary
Nature Medicine

All News & Comment

Cancer screening articles from across Nature Portfolio

Latest Research and Reviews

Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice

Differentiating malignant and benign eyelid lesions using deep learning

Identifying polymorphic cis-regulatory variants as risk markers for lung carcinogenesis and chemotherapy responses in tobacco smokers from eastern India

The imperative for clinical trial diversity: Perspectives in the context of prostate-specific membrane antigen-targeted imaging

The risk of second primary malignancies in colorectal cancer patients using calcium channel blockers

Clinical outcomes of colonoscopic polypectomy with strategic surveillance colonoscopies in patients with 10 or more polyps

News and Comment

Nomograms in PCa: where do we stand

Targeted biopsy reduces detection of clinically insignificant cancer

The emerging promise of liquid biopsies in solid tumors

Genetic risk scores may compound rather than solve the issue of prostate cancer overdiagnosis

From WCC 2022

Uncertain role for colonoscopy screening

Search

Quick links